Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Bfast jobs for analyzing AB's SOLiD data vs Illumina data

    Dear Bfast experts,

    I am aligning paired end reads to the mouse reference genome and the jobs exceed 40hrs for 5M short reads per parallel job.
    Using unpaired option for the analysis each of my parallel jobs take < 5hrs. There are 90 such parallel jobs.
    I am using the following command:

    #bfast postprocess -n $(pcores -N) -U -t -f $tref -A 1 -i $baf > $sam #unpaired
    bfast postprocess -n $(pcores -N) -a 3 -t -f $tref -A 1 -i $baf > $sam # paired end

    Q1- Am I doing something incorrect?
    Q2- I am seeking suggestions to improve the speed but not compromise on accuracy please.
    Q3- Do Illumina and SOLiD paired end analyses differ - so is there a different command to be used.

    Earlier when I was analyzing the mate pair library the jobs took a very long time. From the job logs the actual processing time was really lesser than that, but it seems that the jobs were stuck in a non cpu intensive process.

    Thanks in advance,
    Best,
    bfast analyzer.

  • #2
    The "-U" option really helps, at very little sensitivity/specificity cost.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      Yesterday, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 09-06-2024, 08:02 AM
    0 responses
    138 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-03-2024, 08:30 AM
    0 responses
    141 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 08-27-2024, 04:40 AM
    0 responses
    152 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 08-22-2024, 05:00 AM
    0 responses
    396 views
    0 likes
    Last Post seqadmin  
    Working...
    X